nodes	percent_of_prediction	percent_of_DWPC	metapath
Desoximetasone—Plaque psoriasis—Calcitriol—osteoporosis	0.317	0.34	CcSEcCtD
Desoximetasone—Pigmentation skin—Estradiol—osteoporosis	0.059	0.0633	CcSEcCtD
Desoximetasone—Stinging—Calcium Acetate—osteoporosis	0.0443	0.0475	CcSEcCtD
Desoximetasone—Application site irritation—Estradiol—osteoporosis	0.0388	0.0416	CcSEcCtD
Desoximetasone—Pigmentation disorder—Estradiol—osteoporosis	0.0323	0.0346	CcSEcCtD
Desoximetasone—Allergic contact dermatitis—Estradiol—osteoporosis	0.0308	0.0331	CcSEcCtD
Desoximetasone—Psoriasis—Calcitriol—osteoporosis	0.0304	0.0326	CcSEcCtD
Desoximetasone—Acne—Ethinyl Estradiol—osteoporosis	0.0196	0.021	CcSEcCtD
Desoximetasone—Acne—Estradiol—osteoporosis	0.0128	0.0137	CcSEcCtD
Desoximetasone—Hyperglycaemia—Estropipate—osteoporosis	0.0115	0.0124	CcSEcCtD
Desoximetasone—Pain—Calcium Acetate—osteoporosis	0.0109	0.0117	CcSEcCtD
Desoximetasone—Dermatitis contact—Estradiol—osteoporosis	0.0106	0.0114	CcSEcCtD
Desoximetasone—Erythema—Etidronic acid—osteoporosis	0.0103	0.011	CcSEcCtD
Desoximetasone—Testolactone—CYP19A1—osteoporosis	0.01	0.314	CrCbGaD
Desoximetasone—Pain—Ergocalciferol—osteoporosis	0.00966	0.0104	CcSEcCtD
Desoximetasone—Pruritus—Calcium Acetate—osteoporosis	0.00905	0.00971	CcSEcCtD
Desoximetasone—Erythema—Estropipate—osteoporosis	0.0089	0.00955	CcSEcCtD
Desoximetasone—Erythema—Alendronate—osteoporosis	0.00877	0.00941	CcSEcCtD
Desoximetasone—Erythema—Ibandronate—osteoporosis	0.00854	0.00916	CcSEcCtD
Desoximetasone—Erythema—Calcitriol—osteoporosis	0.00836	0.00897	CcSEcCtD
Desoximetasone—Infection—Etidronic acid—osteoporosis	0.00834	0.00895	CcSEcCtD
Desoximetasone—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.00762	0.00817	CcSEcCtD
Desoximetasone—Infection—Estropipate—osteoporosis	0.00722	0.00774	CcSEcCtD
Desoximetasone—Infection—Alendronate—osteoporosis	0.00711	0.00763	CcSEcCtD
Desoximetasone—Infection—Raloxifene—osteoporosis	0.00699	0.0075	CcSEcCtD
Desoximetasone—Infection—Ibandronate—osteoporosis	0.00692	0.00743	CcSEcCtD
Desoximetasone—Fluoxymesterone—SHBG—osteoporosis	0.00686	0.215	CrCbGaD
Desoximetasone—Erythema—Pamidronate—osteoporosis	0.00669	0.00718	CcSEcCtD
Desoximetasone—Pain—Estropipate—osteoporosis	0.00621	0.00667	CcSEcCtD
Desoximetasone—Pain—Alendronate—osteoporosis	0.00612	0.00657	CcSEcCtD
Desoximetasone—Erythema—Zoledronate—osteoporosis	0.00611	0.00655	CcSEcCtD
Desoximetasone—Hyperglycaemia—Estradiol—osteoporosis	0.0061	0.00654	CcSEcCtD
Desoximetasone—Pain—Raloxifene—osteoporosis	0.00602	0.00646	CcSEcCtD
Desoximetasone—Pain—Ibandronate—osteoporosis	0.00596	0.00639	CcSEcCtD
Desoximetasone—Pruritus—Etidronic acid—osteoporosis	0.00594	0.00638	CcSEcCtD
Desoximetasone—Erythema—Conjugated Estrogens—osteoporosis	0.00588	0.00631	CcSEcCtD
Desoximetasone—Infection—Ethinyl Estradiol—osteoporosis	0.00585	0.00628	CcSEcCtD
Desoximetasone—Pain—Calcitriol—osteoporosis	0.00583	0.00626	CcSEcCtD
Desoximetasone—Infection—Risedronate—osteoporosis	0.00571	0.00612	CcSEcCtD
Desoximetasone—Infection—Pamidronate—osteoporosis	0.00542	0.00582	CcSEcCtD
Desoximetasone—Dermatitis—Etidronic acid—osteoporosis	0.00529	0.00568	CcSEcCtD
Desoximetasone—Pruritus—Estropipate—osteoporosis	0.00514	0.00552	CcSEcCtD
Desoximetasone—Pruritus—Alendronate—osteoporosis	0.00506	0.00543	CcSEcCtD
Desoximetasone—Infection—Zoledronate—osteoporosis	0.00495	0.00531	CcSEcCtD
Desoximetasone—Pruritus—Ibandronate—osteoporosis	0.00493	0.00529	CcSEcCtD
Desoximetasone—Pain—Risedronate—osteoporosis	0.00491	0.00527	CcSEcCtD
Desoximetasone—Pruritus—Calcitriol—osteoporosis	0.00483	0.00518	CcSEcCtD
Desoximetasone—Infection—Conjugated Estrogens—osteoporosis	0.00477	0.00512	CcSEcCtD
Desoximetasone—Erythema—Estradiol—osteoporosis	0.00471	0.00505	CcSEcCtD
Desoximetasone—Pain—Pamidronate—osteoporosis	0.00467	0.00501	CcSEcCtD
Desoximetasone—Fluoxymesterone—ESR1—osteoporosis	0.00464	0.145	CrCbGaD
Desoximetasone—Dermatitis—Estropipate—osteoporosis	0.00458	0.00491	CcSEcCtD
Desoximetasone—Dermatitis—Alendronate—osteoporosis	0.00451	0.00484	CcSEcCtD
Desoximetasone—Dermatitis—Raloxifene—osteoporosis	0.00443	0.00476	CcSEcCtD
Desoximetasone—Dermatitis—Ibandronate—osteoporosis	0.00439	0.00471	CcSEcCtD
Desoximetasone—Dermatitis—Calcitriol—osteoporosis	0.0043	0.00461	CcSEcCtD
Desoximetasone—Pain—Zoledronate—osteoporosis	0.00426	0.00457	CcSEcCtD
Desoximetasone—Hydrocortisone—SHBG—osteoporosis	0.00418	0.131	CrCbGaD
Desoximetasone—Pruritus—Ethinyl Estradiol—osteoporosis	0.00417	0.00447	CcSEcCtD
Desoximetasone—Pain—Conjugated Estrogens—osteoporosis	0.00411	0.00441	CcSEcCtD
Desoximetasone—Pruritus—Risedronate—osteoporosis	0.00406	0.00436	CcSEcCtD
Desoximetasone—Betamethasone—CYP19A1—osteoporosis	0.00393	0.123	CrCbGaD
Desoximetasone—Pruritus—Pamidronate—osteoporosis	0.00386	0.00414	CcSEcCtD
Desoximetasone—Infection—Estradiol—osteoporosis	0.00382	0.0041	CcSEcCtD
Desoximetasone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00371	0.00398	CcSEcCtD
Desoximetasone—Dermatitis—Risedronate—osteoporosis	0.00362	0.00388	CcSEcCtD
Desoximetasone—Pruritus—Zoledronate—osteoporosis	0.00353	0.00378	CcSEcCtD
Desoximetasone—Dermatitis—Pamidronate—osteoporosis	0.00344	0.00369	CcSEcCtD
Desoximetasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.00341	0.0947	CbGpPWpGaD
Desoximetasone—Pruritus—Conjugated Estrogens—osteoporosis	0.0034	0.00364	CcSEcCtD
Desoximetasone—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.00338	0.0939	CbGpPWpGaD
Desoximetasone—Pain—Estradiol—osteoporosis	0.00329	0.00353	CcSEcCtD
Desoximetasone—Dermatitis—Zoledronate—osteoporosis	0.00314	0.00337	CcSEcCtD
Desoximetasone—Dermatitis—Conjugated Estrogens—osteoporosis	0.00302	0.00324	CcSEcCtD
Desoximetasone—Pruritus—Estradiol—osteoporosis	0.00272	0.00292	CcSEcCtD
Desoximetasone—Dermatitis—Estradiol—osteoporosis	0.00242	0.0026	CcSEcCtD
Desoximetasone—Dexamethasone—CYP19A1—osteoporosis	0.00228	0.0716	CrCbGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.0014	0.0389	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.00139	0.0387	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.00137	0.0381	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.00123	0.0342	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.00122	0.034	CbGpPWpGaD
Desoximetasone—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.00119	0.033	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.00117	0.0325	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.0011	0.0307	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.0011	0.0306	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.0011	0.0305	CbGpPWpGaD
Desoximetasone—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.00104	0.0288	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.00103	0.0287	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.00094	0.0261	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000873	0.0243	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.000844	0.0235	CbGpPWpGaD
Desoximetasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.000844	0.0235	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—WNT1—osteoporosis	0.000682	0.0189	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000667	0.0185	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000649	0.018	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.000633	0.0176	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—BMP2—osteoporosis	0.000616	0.0171	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000603	0.0168	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	0.000518	0.0144	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.000511	0.0142	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000461	0.0128	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.00045	0.0125	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.000411	0.0114	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—IRS2—osteoporosis	0.000338	0.00939	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—LEP—osteoporosis	0.000331	0.00919	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—IRS1—osteoporosis	0.000295	0.0082	CbGpPWpGaD
Desoximetasone—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	0.000275	0.00764	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—IGF1—osteoporosis	0.000273	0.00759	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	0.000269	0.00749	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	0.000269	0.00747	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	0.00024	0.00666	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000239	0.00665	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—U2AF1—osteoporosis	0.000239	0.00664	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	0.000202	0.00563	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	0.00019	0.00528	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000182	0.00506	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.000178	0.00496	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—RPL24—osteoporosis	0.000177	0.00493	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—TGFB1—osteoporosis	0.000164	0.00455	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—TNF—osteoporosis	0.000153	0.00425	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	0.000151	0.00419	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000132	0.00367	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—IL6—osteoporosis	0.000123	0.00343	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	0.000115	0.0032	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000107	0.00296	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—PSMA5—osteoporosis	0.000102	0.00285	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—PSMA2—osteoporosis	0.000102	0.00285	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—ESR2—osteoporosis	9.15e-05	0.00254	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—VDR—osteoporosis	7.26e-05	0.00202	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	5.99e-05	0.00167	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—ESR1—osteoporosis	5.55e-05	0.00154	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—MYC—osteoporosis	2.89e-05	0.000802	CbGpPWpGaD
